Stockreport

Gilead Sciences: Analyzing Remdesivir's Potential In A Difficult Time [Seeking Alpha]

Gilead Sciences, Inc.  (GILD) 
Last gilead sciences, inc. earnings: 4/30 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: investors.gilead.com
PDF SummaryGilead Sciences has an impressive portfolio of assets. Remdesivir is performing incredibly well, with the initial data very promising.Past this, the remainder of [Read more]